FDA Inspection 885336 — Biomet, Inc.

Biomet, Inc. — FEI 1825034

The FDA completed an inspection of Biomet, Inc. on June 30, 2014 in Warsaw, IN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 30, 2014
Fiscal Year
2014
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Warsaw, IN (United States)

Additional Details

Postmarket Audit Inspections

Citations

IDCFRDescription
311921 CFR 820.75(b)Lack/Inad procedure-Monitoring/Control of Validated Proces
54621 CFR 820.75(a)Lack of or inadequate process validation